Control of assembly and function of glutamate receptors by the amino-terminal domain

Molecular Pharmacology

Volumn 78, Issue 4, 2010, Pages 535-549

  Hansen, Kasper B ^a   Furukawa, Hiro ^b   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ZINC ION; AMINO ACID RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; BINDING SITE; HUMAN; ISCHEMIA; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

ANIMALS; EXCITATORY AMINO ACID AGONISTS; HUMANS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUTAMATE;

EID: 77957235696     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.067157     Document Type: Short Survey

References (156)

1. Addy C, Assaid C, Hreniuk D, Stroh M, Xu Y, Herring WJ, Ellenbogen A, Jinnah HA, Kirby L, Leibowitz MT, et al. (2009) Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. J Clin Pharmacol 49:856-864.
2. Armstrong N, Jasti J, Beich-Frandsen M, and Gouaux E (2006) Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell 127:85-97. (Pubitemid 44466635)
3. Atlason PT, Garside ML, Meddows E, Whiting P, and McIlhinney RA (2007) N-Methyl-D-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor. J Biol Chem 282:25299-25307.
4. Avenet P, Léonardon J, Besnard F, Graham D, Depoortere H, and Scatton B (1997) Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci Lett 223:133-136. (Pubitemid 27112794)
5. Ayalon G, Segev E, Elgavish S, and Stern-Bach Y (2005) Two regions in the Nterminal domain of ionotropic glutamate receptor 3 form the subunit oligomerization interfaces that control subtype-specific receptor assembly. J Biol Chem 280: 15053-15060. (Pubitemid 40562859)
6. Ayalon G and Stern-Bach Y (2001) Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions. Neuron 31:103-113. (Pubitemid 32757092)
7. Banke TG, Dravid SM, and Traynelis SF (2005) Protons trap NR1/NR2B NMDA receptors in a nonconducting state. J Neurosci 25:42-51.
8. Barta-Szalai G, Borza I, Bozó E, Kiss C, Agai B, Proszenyák A, Keseru GM, Gere A, Kolok S, Galgóczy K, et al. (2004) Oxamides as novel NR2B selective NMDA receptor antagonists. Bioorg Med Chem Lett 14:3953-3956. (Pubitemid 38844403)
9. Borza I and Domány G (2006) NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore. Curr Top Med Chem 6:687-695.
10. Brimecombe JC, Boeckman FA, and Aizenman E (1997) Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 94:11019-11024.
11. Carron C, Jullien A, and Bucher B (1971) Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives. Arzneimittelforschung 21:1992-1998.
12. Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, and MacKenzie ET (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther 247:1222-1232.
13. Chazot PL, Lawrence S, and Thompson CL (2002) Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists. Neuropharmacology 42:319-324.
14. Chazot PL and Stephenson FA (1997) Molecular dissection of native mammalian forebrain NMDA receptors containing the NR1 C2 exon: direct demonstration of NMDA receptors comprising NR1, NR2A, and NR2B subunits within the same complex. J Neurochem 69:2138-2144.
15. Chen N, Moshaver A, and Raymond LA (1997) Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 51:1015-1023.
16. Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF, et al. (2008) Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586:227-245.
17. Chenard BL and Menniti FS (1999) Antagonists selective for NMDA receptors containing the NR2B subunit. Curr Pharm Des 5:381-404.
18. Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, and Fox CB (1991) Separation of α1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J Med Chem 34:3085-3090.
19. 2+ inhibition of the NMDA receptor. Neuron 23:171-180.
20. Christensen BN and Hida E (1990) Protonation of histidine groups inhibits gating of the quisqualate/kainate channel protein in isolated catfish cone horizontal cells. Neuron 5:471-478.
21. Christine CW and Choi DW (1990) Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 10:108-116.
22. Clayton A, Siebold C, Gilbert RJ, Sutton GC, Harlos K, McIlhinney RA, Jones EY, and Aricescu AR (2009) Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors. J Mol Biol 392:1125-1132.
23. Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, and Greenberg ME (2000) EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103:945-956.
24. Das U, Kumar J, Mayer ML, and Plested AJ (2010) Domain organization and function in GluK2 subtype kainate receptors. Proc Natl Acad Sci USA 107:8463-8468.
25. Dingledine R, Borges K, Bowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
26. Erreger K, Dravid SM, Banke TG, Wyllie DJ, and Traynelis SF (2005) Subunitspecific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563:345-358.
27. Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, et al. (2007) Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72:907-920.
28. Erreger K and Traynelis SF (2005) Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J Physiol 569:381-393. (Pubitemid 41830109)
29. Erreger K and Traynelis SF (2008) Zinc inhibition of rat NR1/NR2A N-methyl-Daspartate receptors. J Physiol 586:763-778. (Pubitemid 351194116)
30. 2+ binding to NMDA receptors. Neuron 25:683-694.
31. Fischer G, Mutel V, Trube G, Malherbe P, Kew JN, Mohacsi E, Heitz MP, and Kemp JA (1997) Ro 25-6981, a highly potent and selective blocker of N-methyl-Daspartate receptors containing the NR2B subunit. Characterization in vitro. J Pharmacol Exp Ther 283:1285-1292.
32. Fleck MW, Cornell E, and Mah SJ (2003) Amino-acid residues involved in glutamate receptor 6 kainate receptor gating and desensitization. J Neurosci 23:1219-1227. (Pubitemid 36258900)
33. Gallagher MJ, Huang H, Pritchett DB, and Lynch DR (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271:9603-9611. (Pubitemid 26137366)
34. Gielen M, Le Goff A, Stroebel D, Johnson JW, Neyton J, and Paoletti P (2008) Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. Neuron 57:80-93.
35. Gielen M, Siegler Retchless B, Mony L, Johnson JW, and Paoletti P (2009) Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459:703-707.
36. Giffard RG, Monyer H, Christine CW, and Choi DW (1990) Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res 506:339-342. (Pubitemid 20031623)
37. Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet- Trafit B, Lorez HP, Malherbe P, et al. (2002) Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl- benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist. J Pharmacol Exp Ther 302:940-948. (Pubitemid 34920214)
38. Greger IH, Akamine P, Khatri L, and Ziff EB (2006) Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis. Neuron 51:85-97. (Pubitemid 43963334)
39. Greger IH, Khatri L, and Ziff EB (2002) RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron 34:759-772. (Pubitemid 34628738)
40. Greger IH, Ziff EB, and Penn AC (2007) Molecular determinants of AMPA receptor subunit assembly. Trends Neurosci 30:407-416. (Pubitemid 47088718)
41. Grunwald ME and Kaplan JM (2003) Mutations in the ligand-binding and pore domains control exit of glutamate receptors from the endoplasmic reticulum in C. elegans. Neuropharmacology 45:768-776.
42. Han X, Tomitori H, Mizuno S, Higashi K, Füll C, Fukiwake T, Terui Y, Leewanich P, Nishimura K, Toida T, et al. (2008) Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor. J Neurochem 107:1566-1577.
43. Hansen KB, Bräuner-Osborne H, and Egebjerg J (2008) Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements. Comb Chem High Throughput Screen 11:304-315. (Pubitemid 351720824)
44. Hansen KB, Mullasseril P, Dawit S, Kurtkaya NL, Yuan H, Vance KM, Orr AG, Kvist T, Ogden KK, Le P, et al. (2010) Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists. J Pharmacol Exp Ther 333:650-662.
45. Hansen KB, Naur P, Kurtkaya NL, Kristensen AS, Gajhede M, Kastrup JS, and Traynelis SF (2009) Modulation of the dimer interface at ionotropic glutamate-like receptor delta2 by D-serine and extracellular calcium. J Neurosci 29:907-917.
46. Hatton CJ and Paoletti P (2005) Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46:261-274.
47. Hess SD, Daggett LP, Deal C, Lu CC, Johnson EC, and Veliçelebi G (1998) Functional characterization of human N-methyl-D-aspartate subtype 1A/2D receptors. J Neurochem 70:1269-1279.
48. Horning MS and Mayer ML (2004) Regulation of AMPA receptor gating by ligand binding core dimers. Neuron 41:379-388.
49. Ihle EC and Patneau DK (2000) Modulation of alpha-amino-3-hydroxy-5- methyl-4- isoxazolepropionic acid receptor desensitization by extracellular protons. Mol Pharmacol 58:1204-1212.
50. Ilyin VI, Whittemore ER, Guastella J, Weber E, and Woodward RM (1996) Subtypeselective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol Pharmacol 50:1541-1550.
51. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, and Masu M (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
52. Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y, and Gouaux E (2009) Crystal structure and association behaviour of the GluR2 amino-terminal domain. EMBO J 28:1812-1823.
53. Kakegawa W, Kohda K, and Yuzaki M (2007a) The delta2 'ionotropic' glutamate receptor functions as a non-ionotropic receptor to control cerebellar synaptic plasticity. J Physiol 584:89-96.
54. 2+ permeability of the channel pore is not essential for the Delta2 glutamate receptor to regulate synaptic plasticity and motor coordination. J Physiol 579:729-735.
55. Karakas E, Simorowski N, and Furukawa H (2009) Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28:3910-3920.
56. Kawai M, Nakamura H, Sakurada I, Shimokawa H, Tanaka H, Matsumizu M, Ando K, Hattori K, Ohta A, Nukui S, et al. (2007) Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity. Bioorg Med Chem Lett 17:5533-5536.
57. Kawajiri S and Dingledine R (1993) Multiple structural determinants of voltage-dependent magnesium block in recombinant NMDA receptors. Neuropharmacology 32:1203-1211.
58. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, et al. (2009) Predicting new molecular targets for known drugs. Nature 462:175-181.
59. Kew JN and Kemp JA (1998) An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones. J Physiol 512: 17-28.
60. Kew JN, Trube G, and Kemp JA (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. J Physiol 497:761-772.
61. Kew JN, Trube G, and Kemp JA (1998) State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist. Br J Pharmacol 123:463-472.
62. Kumar J, Schuck P, Jin R, and Mayer ML (2009) The N-terminal domain of GluR6-subtype glutamate receptor ion channels. Nat Struct Mol Biol 16:631-638.
63. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407:971-977.
64. Kuroyanagi T, Yokoyama M, and Hirano T (2009) Postsynaptic glutamate receptor delta family contributes to presynaptic terminal differentiation and establishment of synaptic transmission. Proc Natl Acad Sci USA 106:4912-4916.
65. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, and Arakawa M (1992) Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
66. Kuusinen A, Abele R, Madden DR, and Keinänen K (1999) Oligomerization and ligand-binding properties of the ectodomain of the alpha-amino-3-hydroxy-5- methyl-4-isoxazole propionic acid receptor subunit GluRD. J Biol Chem 274:28937-28943. (Pubitemid 129625615)
67. Layton ME, Kelly MJ 3rd, and Rodzinak KJ (2006) Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. Curr Top Med Chem 6:697-709.
68. Legendre P and Westbrook GL (1991) Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol Pharmacol 40:289-298.
69. Lei S, Orser BA, Thatcher GR, Reynolds JN, and MacDonald JF (2001) Positive allosteric modulators of AMPA receptors reduce proton-induced receptor desensitization in rat hippocampal neurons. J Neurophysiol 85:2030-2038. (Pubitemid 32440681)
70. Leuschner WD and Hoch W (1999) Subtype-specific assembly of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is mediated by their N-terminal domains. J Biol Chem 274:16907-16916. (Pubitemid 129519016)
71. Liverton NJ, Bednar RA, Bednar B, Butcher JW, Claiborne CF, Claremon DA, Cunningham M, DiLella AG, Gaul SL, Libby BE, et al. (2007) Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1- carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-Daspartate receptor antagonist. J Med Chem 50:807-819. (Pubitemid 46332992)
72. Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, et al. (2003) Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol Pharmacol 63:1212-1222. (Pubitemid 36627215)
73. Low CM, Zheng F, Lyuboslavsky P, and Traynelis SF (2000) Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc Natl Acad Sci USA 97:11062-11067.
74. Luo J, Wang Y, Yasuda RP, Dunah AW, and Wolfe BB (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51:79-86. (Pubitemid 27049548)
75. 2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors. Mol Pharmacol 72:1535-1544.
76. Mah SJ, Cornell E, Mitchell NA, and Fleck MW (2005) Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function. J Neurosci 25:2215-2225. (Pubitemid 40322262)
77. Malherbe P, Mutel V, Broger C, Perin-Dureau F, Kemp JA, Neyton J, Paoletti P, and Kew JN (2003) Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. J Pharmacol Exp Ther 307:897-905. (Pubitemid 37494206)
78. Mansour M, Nagarajan N, Nehring RB, Clements JD, and Rosenmund C (2001) Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement. Neuron 32:841-853. (Pubitemid 34024845)
79. Marinelli L, Cosconati S, Steinbrecher T, Limongelli V, Bertamino A, Novellino E, and Case DA (2007) Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. ChemMedChem 2:1498-1510.
80. Masuko T, Kashiwagi K, Kuno T, Nguyen ND, Pahk AJ, Fukuchi J, Igarashi K, and Williams K (1999) A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol Pharmacol 55:957-969. (Pubitemid 29252360)
81. Matsuda K, Miura E, Miyazaki T, Kakegawa W, Emi K, Narumi S, Fukazawa Y, Ito-Ishida A, Kondo T, Shigemoto R, et al. (2010) Cbln1 is a ligand for an orphan glutamate receptor Delta2, a bidirectional synapse organizer. Science 328:363-368.
82. Matsuda S, Kamiya Y, and Yuzaki M (2005) Roles of the N-terminal domain on the function and quaternary structure of the ionotropic glutamate receptor. J Biol Chem 280:20021-20029.
83. Mayer ML, Vyklicky L Jr, and Clements J (1989) Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature 338:425-427.
84. McCauley JA, Theberge CR, Romano JJ, Billings SB, Anderson KD, Claremon DA, Freidinger RM, Bednar RA, Mosser SD, Gaul SL, et al. (2004) NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles. J Med Chem 47:2089-2096.
85. Meddows E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P, and McIlhinney RA (2001) Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem 276:18795-18803.
86. Misra C, Brickley SG, Wyllie DJ, and Cull-Candy SG (2000) Slow deactivation kinetics of NMDA receptors containing NR1 and NR2D subunits in rat cerebellar Purkinje cells. J Physiol 525:299-305.
87. Mony L, Kew JN, Gunthorpe MJ, and Paoletti P (2009a) Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential. Br J Pharmacol 157:1301-1317.
88. Mony L, Krzaczkowski L, Leonetti M, Le Goff A, Alarcon K, Neyton J, Bertrand HO, Acher F, and Paoletti P (2009b) Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mol Pharmacol 75:60-74.
89. Monyer H, Burnashev N, Laurie DJ, Sakmann B, and Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
90. Mosley CA, Myers SJ, Murray EE, Santangelo R, Tahirovic YA, Kurtkaya N, Mullasseril P, Yuan H, Lyuboslavsky P, Le P, et al. (2009) Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors. Bioorg Med Chem 17:6463-6480.
91. Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF, and Dingledine R (1998) Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1:659-667.
92. Mott DD, Washburn MS, Zhang S, and Dingledine RJ (2003) Subunit-dependent modulation of kainate receptors by extracellular protons and polyamines. J Neurosci 23:1179-1188.
93. Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL, Santangelo R, Orr AG, Le P, Vellano KM, et al. (2010) A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun, in press.
94. Nagy J, Boros A, Dezso P, Kolok S, and Fodor L (2003) Inducible expression and pharmacology of recombinant NMDA receptors, composed of rat NR1a/NR2B subunits. Neurochem Int 43:19-29.
95. Nahum-Levy R, Lipinski D, Shavit S, and Benveniste M (2001) Desensitization of NMDA receptor channels is modulated by glutamate agonists. Biophys J 80:2152-2166.
96. Nakagawa T, Cheng Y, Ramm E, Sheng M, and Walz T (2005) Structure and different conformational states of native AMPA receptor complexes. Nature 433: 545-549.
97. Naur P, Hansen KB, Kristensen AS, Dravid SM, Pickering DS, Olsen L, Vestergaard B, Egebjerg J, Gajhede M, Traynelis SF, et al. (2007) Ionotropic glutamate-like receptor delta2 binds D-serine and glycine. Proc Natl Acad Sci USA 104:14116-14121.
98. Ng FM, Geballe MT, Snyder JP, Traynelis SF, and Low CM (2008) Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies. Mol Brain 1:16.
99. Nikam SS and Meltzer LT (2002) NR2B selective NMDA receptor antagonists. Curr Pharm Des 8:845-855.
100. O'Brien RJ, Xu D, Petralia RS, Steward O, Huganir RL, and Worley P (1999) Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. Neuron 23:309-323.
101. O'Hara PJ, Sheppard PO, Thøgersen H, Venezia D, Haldeman BA, McGrane V, Houamed KM, Thomsen C, Gilbert TL, and Mulvihill ER (1993) The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron 11:41-52.
102. Paas Y (1998) The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci 21:117-125.
103. Paas Y, Eisenstein M, Medevielle F, Teichberg VI, and Devillers-Thiéry A (1996) Identification of the amino acid subsets accounting for the ligand binding specificity of a glutamate receptor. Neuron 17:979-990.
104. Pahk AJ and Williams K (1997) Influence of extracellular PH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci Lett 225:29-32.
105. Paoletti P, Ascher P, and Neyton J (1997) High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17:5711-5725.
106. Paoletti P, Perin-Dureau F, Fayyazuddin A, Le Goff A, Callebaut I, and Neyton J (2000) Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron 28:911-925.
107. Papadakis M, Hawkins LM, and Stephenson FA (2004) Appropriate NR1-NR1 disulfide- linked homodimer formation is requisite for efficient expression of functional, cell surface N-methyl-D-aspartate NR1/NR2 receptors. J Biol Chem 279: 14703-14712.
108. Partin KM, Patneau DK, Winters CA, Mayer ML, and Buonanno A (1993) Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11:1069-1082.
109. Passafaro M, Nakagawa T, Sala C, and Sheng M (2003) Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 424:677-681.
110. Pasternack A, Coleman SK, Jouppila A, Mottershead DG, Lindfors M, Pasternack M, and Keinänen K (2002) Alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA) receptor channels lacking the N-terminal domain. J Biol Chem 277:49662-49667.
111. Penn AC, Williams SR, and Greger IH (2008) Gating motions underlie AMPA receptor secretion from the endoplasmic reticulum. EMBO J 27:3056-3068.
112. Perin-Dureau F, Rachline J, Neyton J, and Paoletti P (2002) Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J Neurosci 22:5955-5965.
113. Peters S, Koh J, and Choi DW (1987) Zinc selectively blocks the action of N-methyl- D-aspartate on cortical neurons. Science 236:589-593.
114. Popescu G and Auerbach A (2003) Modal gating of NMDA receptors and the shape of their synaptic response. Nat Neurosci 6:476-483. (Pubitemid 36514695)
115. Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, and Landen JW (2008) An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol 28:631-637.
116. Priel A, Selak S, Lerma J, and Stern-Bach Y (2006) Block of kainate receptor desensitization uncovers a key trafficking checkpoint. Neuron 52:1037-1046.
117. Qiu S, Hua YL, Yang F, Chen YZ, and Luo JH (2005) Subunit assembly of N-methyl- D-aspartate receptors analyzed by fluorescence resonance energy transfer. J Biol Chem 280:24923-24930.
118. Qiu S, Zhang XM, Cao JY, Yang W, Yan YG, Shan L, Zheng J, and Luo JH (2009) An endoplasmic reticulum retention signal located in the extracellular aminoterminal domain of the NR2A subunit of N-methyl-D-aspartate receptors. J Biol Chem 284:20285-20298.
119. Rachline J, Perin-Dureau F, Le Goff A, Neyton J, and Paoletti P (2005) The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. J Neurosci 25:308-317.
120. Saglietti L, Dequidt C, Kamieniarz K, Rousset MC, Valnegri P, Thoumine O, Beretta F, Fagni L, Choquet D, Sala C, et al. (2007) Extracellular interactions between GluR2 and N-cadherin in spine regulation. Neuron 54:461-477.
121. Schorge S and Colquhoun D (2003) Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits. J Neurosci 23:1151-1158.
122. Schüler T, Mesic I, Madry C, Bartholomäus I, and Laube B (2008) Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-Daspartate receptor assembly. J Biol Chem 283:37-46.
123. Sia GM, Béïque JC, Rumbaugh G, Cho R, Worley PF, and Huganir RL (2007) Interaction of the N-terminal domain of the AMPA receptor GluR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment. Neuron 55:87-102. (Pubitemid 46990823)
124. Sobolevsky AI, Rosconi MP, and Gouaux E (2009) X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462:745-756.
125. Sun Y, Olson R, Horning M, Armstrong N, Mayer M, and Gouaux E (2002) Mechanism of glutamate receptor desensitization. Nature 417:245-253.
126. Tahirovic YA, Geballe M, Gruszecka-Kowalik E, Myers SJ, Lyuboslavsky P, Le P, French A, Irier H, Choi WB, Easterling K, et al. (2008) Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists. J Med Chem 51:5506-5521.
127. Takasu MA, Dalva MB, Zigmond RE, and Greenberg ME (2002) Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 295:491-495.
128. Tamiz AP, Cai SX, Zhou ZL, Yuen PW, Schelkun RM, Whittemore ER, Weber E, Woodward RM, and Keana JF (1999) Structure-activity relationship of N- (phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists. J Med Chem 42:3412-3420.
129. Tamiz AP, Whittemore ER, Zhou ZL, Huang JC, Drewe JA, Chen JC, Cai SX, Weber E, Woodward RM, and Keana JF (1998) Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl- D-aspartate receptors. J Med Chem 41:3499-3506. (Pubitemid 28406558)
130. +. Proc Natl Acad Sci USA 87:6445-6449.
131. Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P, and Powers JL (1998) Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 18:6163-6175.
132. Traynelis SF and Cull-Candy SG (1990) Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345:347-350. (Pubitemid 20159541)
133. Traynelis SF, Hartley M, and Heinemann SF (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268:873-876.
134. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, and Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev doi:10.1124/pr.109.002451.
135. Uemura T, Lee SJ, Yasumura M, Takeuchi T, Yoshida T, Ra M, Taguchi R, Sakimura K, and Mishina M (2010) Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 141:1068-1079.
136. Valluru L, Xu J, Zhu Y, Yan S, Contractor A, and Swanson GT (2005) Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors. J Biol Chem 280:6085-6093.
137. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, and Grayson DR (1998) Functional and pharmacological differences between recombinant N-methyl- D-aspartate receptors. J Neurophysiol 79:555-566. (Pubitemid 28095877)
138. Vyklický L Jr, Vlachová V, and Krůsek J (1990) The effect of external PH changes on responses to excitatory amino acids in mouse hippocampal neurones. J Physiol 430:497-517.
139. Wang CX and Shuaib A (2005) NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord 4:143-151.
140. Wells GB, Lin L, Jeanclos EM, and Anand R (2001) Assembly and ligand binding properties of the water-soluble extracellular domains of the glutamate receptor 1 subunit. J Biol Chem 276:3031-3036. (Pubitemid 37411592)
141. 2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328:640-643.
142. Weston MC, Schuck P, Ghosal A, Rosenmund C, and Mayer ML (2006) Conformational restriction blocks glutamate receptor desensitization. Nat Struct Mol Biol 13:1120-1127. (Pubitemid 44885924)
143. Whittemore ER, Ilyin VI, Konkoy CS, and Woodward RM (1997a) Subtype-selective antagonism of NMDA receptors by nylidrin. Eur J Pharmacol 337:197-208.
144. Whittemore ER, Ilyin VI, and Woodward RM (1997b) Antagonism of N-methyl-D- aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther 282:326-338.
145. Williams K (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851-859.
146. Williams K (1996) Separating dual effects of zinc at recombinant N-methyl-Daspartate receptors. Neurosci Lett 215:9-12.
147. Wo ZG and Oswald RE (1995) Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci 18:161-168.
148. Wong E, Ng FM, Yu CY, Lim P, Lim LH, Traynelis SF, and Low CM (2005) Expression and characterization of soluble amino-terminal domain of NR2B subunit of N-methyl-D-aspartate receptor. Protein Sci 14:2275-2283. (Pubitemid 41252796)
149. Wright JL, Gregory TF, Kesten SR, Boxer PA, Serpa KA, Meltzer LT, Wise LD, Espitia SA, Konkoy CS, Whittemore ER, et al. (2000) Subtype-selective N-methyl- D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)- 4-benzylpiperidines. J Med Chem 43:3408-3419.
150. Wu X and Christensen BN (1996) Proton inhibition of the NMDA-gated channel in isolated catfish cone horizontal cells. Vision Res 36:1521-1528. (Pubitemid 26168373)
151. Xu D, Hopf C, Reddy R, Cho RW, Guo L, Lanahan A, Petralia RS, Wenthold RJ, O'Brien RJ, and Worley P (2003) Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. Neuron 39:513-528. (Pubitemid 36937051)
152. Yuan H, Hansen KB, Vance KM, Ogden KK, and Traynelis SF (2009a) Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29:12045-12058.
153. Yuan H, Vance KM, Junge CE, Geballe MT, Snyder JP, Hepler JR, Yepes M, Low CM, and Traynelis SF (2009b) The serine protease plasmin cleaves the
154. Yurkewicz L, Weaver J, Bullock MR, and Marshall LF (2005) The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J Neurotrauma 22:1428-1443. (Pubitemid 43122358)
155. Zhang XX, Bunney BS, and Shi WX (2000) Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil. Synapse 37:56-63.
156. Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ, and Traynelis SF (2001) Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 4:894-901. (Pubitemid 32801592)